Comedian Jim Gaffigan admits he lost 50 pounds using Mounjaro
Jim Gaffigan shared his weight loss journey with Mounjaro, as he shed 50 pounds. Celebrities like Rosie O’Donnell and Amy Schumer also credited the diabetes drug.
GLP-1 prescriptions surge in US: 7 study notes
In 2024, 4% of U.S. adults were prescribed a GLP-1 therapy — a 363.7% increase from 0.9% in 2019, according to a Fair Health analysis of more than 51 billion commercial claim records. Fair Health also found that, over those six years, the percentage of adults with a GLP-1 prescription for obesity or overweight increased […]
The role of GLP-1 receptor agonists in the management of obesity
As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the rapidly evolving use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as Ozempic in the Australian health care system.
Fractyl Rejuva GLP-1 Gene Therapy Data at ASGCT 2025
The sources discuss Fractyl Health’s Rejuva GLP-1 gene therapy platform, highlighting preclinical data presented at ASGCT 2025 for its candidate RJVA-001. This research indicates that a single dose of RJVA-001 in animal models durably improves metabolic markers related to type 2 diabetes and obesity, achieving similar effects as existing GLP-1 drugs but with significantly lower systemic exposure, potentially leading to fewer […]
GLP-1 drugs are life-changing — let’s remove their stigma
I have struggled with my weight my entire life — sometimes less successfully (hello, cooking school in Paris) and sometimes much more successfully. Prior to becoming pregnant, I can’t remember a single time in my life that I wasn’t on a diet or some special workout kick, or whatever it might be. This led me […]
The Dark And Light Side Of Ozempic: Here’s What Experts Say About The Popular Diet Medicine
Not that long ago, it was found that 1 in 8 adults in the United States has taken Ozempic or a similar medicine. While some of them take it for their diabetes, others, as you probably know, take it as a way to lose weight. This usage has become so common that some have dubbed […]
Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom
Post Content
GLP-1 Use and Fatigue
ChatGPTMay 26, 2025 Fatigue or low energy is a commonly reported side effect among users of GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound), but it is not as well characterized or studied as gastrointestinal effects. Here’s what is currently known: 🔍 What We Know About Fatigue and GLP-1 Use ✅ PrevalenceFatigue is reported […]
Study compares Zepbound and Wegovy for weight loss in direct comparison
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New England Journal of Medicine. Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a […]
Ozempic teeth, face and tongue: Side effects of GLP-1 drugs explained
As the use of weight-loss injections rises, users report effects like Ozempic face, tongue, and teeth- here is what these mean and how to manage them